diazan has been researched along with Carcinoma, Hepatocellular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Djachkovskaya, RF; Emanuel, NM; Konovalova, NP | 1 |
1 other study(ies) available for diazan and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Antitumor activity of 1,2-bis diazoacetyl ethane.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Azo Compounds; Carcinoma, Hepatocellular; Diazonium Compounds; Drug Evaluation, Preclinical; Lethal Dose 50; Leukemia L1210; Leukocyte Count; Liver Neoplasms; Melanoma; Mice; Neoplasms, Experimental; Rats; Spleen; Succinates | 1976 |